NHI Q4 net income $0.95/diluted share; introduces 2025 FFO guidance $4.59-$4.66

NATIONAL HEALTH INVESTORS INC

2024-FY EPS reported $3.13 revenue$335,181,000

Q4 2024 NAREIT FFO per diluted share $1.24 (up from $1.09 YoY); Normalized FFO $1.12 vs $1.09.
Full-year 2024 normalized FFO $4.44 (up from $4.33 YoY); Normalized FAD $204.2M vs $187.8M.
2025 guidance: NAREIT/Normalized FFO per diluted share $4.59-$4.66; assumes $225M new investments at 8.1% yield.
Closed $237.5M in acquisitions in 2024 (most active since 2019); signed LOIs for $152.3M at ~8.2% yield.
SHOP occupancy reached 90% in Jan 2025 vs 84.4% a year ago; SLM credit loss reserve $14.8M on non-performing loans.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.